# Aeon Biotherapeutics Corp. – FDA Inspection, Mar 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/aeon-biotherapeutics-corp/7b2d43e4-f8d8-4fe0-a0f2-5b7d8409b671
Source feed: FDA_Inspections

> FDA inspection 1265004 of Aeon Biotherapeutics Corp., March 07, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 820. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265004
- Company Name: Aeon Biotherapeutics Corp.
- Inspection Date: 2025-03-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Officers

- [Company Rep](https://www.keypedia.com/people/alexander-m-kay/0b791400-16cd-45d9-b39d-ad832a6cbe9a)
- [Issuing Officer](https://www.keypedia.com/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)
- [Issuing Officer](https://www.keypedia.com/people/nisha-c-patel/1b38764f-c7bc-4f90-9af1-54989ad6d59c)

Company: https://www.keypedia.com/companies/aeon-biotherapeutics-corp/14a7b58b-e4ee-422d-a423-3806fdb8b038

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8